Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-004573

Options or other derivatives

  • Chief Financial Officer acquired 195,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Moran Sean F. · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-01-18 Grant or award : show line 1 in the form Stock Option(right to buy) +195,000 $7.53 2029-01-18 195,000 195,000 D
Loading xslF345X03/doc4.xml…